Contact Us

Defective Drugs
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

Phone 

Cell Phone 

Street Address 

Zip Code 

City 

State 

   * Name of drug: 

Date you started taking this drug:

Date you stopped taking this drug:

Please describe side effects:

For verification purposes, please answer the below question:
+
=

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.


Azathioprine 50mg Pills Recalled By FDA And Roxane Labs

Jul 18, 2006 | www.medindia.net

The U.S. Food and Drug Administration (FDA) and Roxane Labs have issued a nationwide recall of 50mg Azathioprine tablets, which are used in patients with severe rheumatoid arthritis as well as in kidney transplant patients to prevent rejection.

"It was discovered that a single bottle of Azathioprine tablets from lot 558470A contained Methotrexate tablets USP 2.5 mg. While we believe this issue may be limited to this single bottle, which was not dispensed to a patient, the decision was made to recall manufacturing lot 558470A in order to preclude any possibility of another such bottle being dispensed or used," the FDA said.

The recall alert also said that if Methotrexate 2.5 mg tablets are taken in place of Azathioprine 50 mg tablets there could be serious adverse effects.

"Effects may include decreased resistance to infection, mouth ulcers, reduced blood counts, vomiting, diarrhea, liver, kidney or lung injury. There have also been reports of death at high doses of Methotrexate, such as might result from a substitution of Methotrexate 2.5 mg tablets for Azathioprine 50 mg tablets," it warned.


Related articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo